Since she joined the Crick in 2015, Veronique has established translational science capabilities, an operational structure to enable a diverse portfolio of translatable projects and a culture of entrepreneurship.
Veronique’s business acumen has been honed through developing and delivering business plans, creating six spin outs from academic research supported by venture capital (VC) investment, and licensing deals. She mentors young entrepreneurs and is a member of various biotech boards.
Veronique has 20 years' drug discovery and development experience in industry. She led multidisciplinary research teams and provided strategic leadership on translational work and clinical research programmes. She led the allergic inflammation discovery performance unit at GSK and implemented experimental medicine plans in order to change the way medicines are developed.